Riskpilot← Back to searchSign inGet full accessDottrina Medica AB
ABActiveOrg 5569653370Strömsgatan 22General medical practice activities · NACE 8621Est. 20141 employees
Revenue 2025
SEK 0
EBITDA margin
—
-120% vs 2024
Equity ratio
99.3%
Financial strength
Net profit 2025
SEK 8K
+182% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -22K | -120% |
| Net profit | SEK 8K | +182% |
| Total assets | SEK 857K | -19% |
| Equity | SEK 851K | -18% |
| Employees | 1 | — |
Legal name
Dottrina Medica AB
Org number
5569653370
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 mars 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva konsultverksamhet inom allmän medicin, fastighetsförvaltning, konstnärlig verksamhet inom design och författarskap. Ekonomisk förvaltning av bolagets tillgångar.
Address
Strömsgatan 22
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 360 | 403 | 384 | 0 | 0 |
| Staff expenses | — | — | −82 | −0 | — |
| EBITDA | 343 | 324 | 287 | −10 | −22 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 343 | 324 | 287 | −10 | −22 |
| Net financials | — | — | 0 | 0 | 30 |
| Profit before tax | 342 | 324 | 287 | −10 | 8 |
| Tax | −73 | −67 | −59 | — | — |
| Net profit | 269 | 257 | 228 | −10 | 8 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 249 | 1 323 | 1 351 | 1 053 | 857 |
| Equity | 1 135 | 1 202 | 1 243 | 1 038 | 851 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 114 | 121 | 107 | 14 | 6 |
| Total debt | 114 | 121 | 107 | 14 | 6 |
EBITDA margin
-2232600.0%
This company
15.8%
Market median
-14130480% vs market
20212025
Equity ratio
99.3%
This company
38.2%
Market median
+160% vs market
20212025
Return on equity
1.0%
This company
18.4%
Market median
-95% vs market
20212025
Net profit margin
811600.0%
This company
8.1%
Market median
+10019653% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dottrina Medica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Erik Eriksson | Board of Directors | 0 companies |
| Jenny Elsa Mari Brantestad | Deputy Board Member | 0 companies |